Headache Disorders: How Can We Better Manage the Pain?

Headache Disorders: How Can We Better Manage the Pain?

Headache Disorders: How Can We Better Manage the Pain?
The enduring audio activity includes an interview with two expert headache faculty that will discuss advances in diagnosis and treatment of headache

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Treating primary headache disorders can frustrate patients and confound their physicians. However, science is catching up. We'll explore the complexity of the condition and the promise of new therapeutic approaches in an interactive update led by expert faculty: Merle L. Diamond, MD, with host Andrew Wilner, MD.  

  • Disclosure of Conflicts of Interest

    Educational activities provided by Forefront Collaborative must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s)*. For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias. Disclosures appear below. 

    *The ACCME defines a commercial interest as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by or used on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. 

    The following individuals have indicated that neither they nor their spouses/partners have had, in the past 12 months, financial relationship(s) with commercial interests relative to the content of this CME activity: 

    • Planner (Forefront Collaborative): Sydney Pate  

    The following individuals have disclosed that they and/or their spouse/partner has had a financial relationship in the past 12 months:

    • Planner (Forefront Collaborative): Lily Zurkovsky, PhD, has disclosed that she received salary from and has personal stock in Teva Pharmaceuticals
    • Faculty: Merle L. Diamond, MD has been on an advisory board for Alder Biopharmaceuticals, Allergan, Amgen, Depomed, Lilly, and Supernus; she has consulted for Avanir, Lilly, and Pernix and been on a speaker's bureau for Avanir, Depomed, Pernix, and Teva.

    CME Content Review
    The content of this activity was independently peer reviewed by two reviewers. The reviewers of this activity have no relevant financial relationships to disclose

  • Target Audience

    This activity is designed for headache specialists and primary care physicians. Other healthcare professionals who care for patients with headache may also benefit from participation in the educational activity

  • Learning Objectives

    Upon completion of this part of the activity, participants should be able to:
    1. Discuss the prevalence, epidemiology, and burden of migraine
    2. Develop optimal plans for acute and preventive treatment of migraine, incorporating pharmacologic and nonpharmacologic options as appropriate to the individual patient
    3. Describe newly characterized mechanisms of migraine pathophysiology
    4. Effectively communicate with patients to identify and diagnose primary headache disorders, including but not limited to migraine and cluster
    5. Analyze new clinical trial data addressing safety and efficacy of emerging treatments for primary headache disorders

  • Accreditation and Credit Designation Statements

    Forefront Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation for Enduring

    Forefront Collaborative designates this live activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

    The American Board of Psychiatry and Neurology has reviewed Headache Disorders: How Can We Better Manage the Pain and has approved this program as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification. 

  • Commercial Support

    This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

  • Terms of Use

    This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. Forefront Collaborative does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings

  • Disclaimer

    The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views or recommendations of Forefront Collaborative. 

    This continuing medical education activity will include reference(s) to unlabeled or unapproved uses of drugs or devices. 

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

Sign-up for the Global Neurology Academy newsletters.
Comprehensive Neurology Education.

Better education for a better you.

* Required

Join the Global Neurology Academy of learners.
Registration is free and easy.

Register Now